A Study To Evaluate the Safety of XW001 Inhalation in Children With RSV

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 20, 2023

Primary Completion Date

October 10, 2023

Study Completion Date

January 8, 2024

Conditions

RSV Infection

Interventions

DRUG

XW001

Inhalation solution

DRUG

Placebo

Inhalation solution with matched volume

Trial Locations (1)

West China Second University Hospital, Sichuan University, Chengdu

All Listed Sponsors

lead

Hangzhou Sciwind Biosciences Co., Ltd.

INDUSTRY